Introduction {#sec1}
============

The monoterpene indole alkaloids (MIAs) are a highly diverse family of natural products that are produced in a wide variety of medicinal plants. Over 3000 members of this natural product class, which includes compounds such as quinine, vinblastine, reserpine, and yohimbine, are derived from a common biosynthetic intermediate, strictosidine aglycone ([@bib27]). How plants transform strictosidine aglycone into divergent structural classes has remained unresolved.

The recent availability of transcriptome and genome data has dramatically accelerated the rate at which new plant biosynthetic genes are discovered. All genes that lead to strictosidine aglycone have been recently cloned from the well-characterized medicinal plant *Catharanthus roseus*, which produces over 100 MIAs ([@bib9]). However, gene products that act on strictosidine aglycone have not been identified in any plant, despite decades of effort. Attempts have been hampered in part by the reactivity and instability of strictosidine aglycone. In *C. roseus*, there are at least two major pathway branches derived from strictosidine aglycone ([@bib27]). One pathway is hypothesized to lead to the aspidosperma and the iboga classes to yield the precursors of vinblastine, while the other is expected to lead to alkaloids of the heteroyohimbine type ([Figure 1](#fig1){ref-type="fig"}A). These alkaloids have diverse biological activities: vinblastine is used as an anticancer agent ([@bib22]) and the heteroyohimbines have a range of pharmacological uses ([@bib7; @bib11]). While it is unknown how many *C. roseus* enzymes use strictosidine aglycone as a substrate, there is clearly more than one enzyme that acts at this crucial branchpoint.

The biochemical pathway leading from strictosidine aglycone to the heteroyohimbine alkaloids has been previously investigated using both crude plant extracts and biomimetic chemistry. Reduction of strictosidine aglycone with NaBH~4~ or NaCNBH~3~ yielded the heteroyohimbines ajmalicine (raubasine), tetrahydroalstonine, and 19-epi-ajmalicine, which differ only in the stereochemical configuration at carbons 15, 19, and 20, in various ratios ([Figure 1](#fig1){ref-type="fig"}B) ([@bib4; @bib19; @bib20; @bib21]). These three diastereomers were again observed, also in varying relative amounts, when crude *C. roseus* protein extracts were incubated with strictosidine aglycone and NADPH, but not in the absence of NADPH ([@bib28; @bib30; @bib31; @bib32; @bib35]). Collectively, these observations indicate that the heteroyohimbines result directly from the reduction of strictosidine aglycone and that an NADPH-dependent enzyme is implicated in this process. However, no gene encoding such an enzyme has been identified. Here we report the discovery of a reductase that converts strictosidine aglycone to the heteroyohimbine alkaloid tetrahydroalstonine.

Results and Discussion {#sec2}
======================

Given that heteroyohimbine biosynthesis likely requires reduction of an iminium present in strictosidine aglycone ([Figure 1](#fig1){ref-type="fig"}B), we used a publically available RNA-seq database that we recently generated ([@bib15]) to search for *C. roseus* candidates displaying homology to enzyme classes known to reduce the carbonyl functional group. The alcohol dehydrogenases (ADHs), enzymes that reduce aldehydes and ketones to alcohols, were chosen as the initial focus. As part of a screen of ADHs that are upregulated in response to methyl jasmonate ([@bib15]), a hormone known to upregulate alkaloid biosynthesis, we identified a candidate annotated as sinapyl alcohol dehydrogenase ([Supplemental Information](#app2){ref-type="sec"}). When heterologously expressed and purified from *E. coli* ([Figure S1](#app2){ref-type="sec"}), and assayed with strictosidine aglycone and NADPH, this candidate yielded a product with a mass consistent with a heteroyohimbine (*m*/*z* 353.1855), thereby implicating this enzyme in the important structural branchpoint of the MIA biosynthetic pathway ([Figure 2](#fig2){ref-type="fig"}A).

To determine the identity of the alkaloid product, the enzyme was incubated with purified strictosidine (4.3 mg) in the presence of strictosidine glucosidase (SGD), which generated strictosidine aglycone in situ to best mimic physiologically relevant conditions. The major product (approximately 1 mg) was isolated by preparative thin-layer chromatography and exhibited an ^1^H-NMR and ^13^C-NMR spectrum matching an authentic standard of tetrahydroalstonine ([Figure 2](#fig2){ref-type="fig"}B; [Figure S2](#app2){ref-type="sec"}). [@bib18] previously reported the isolation of an enzyme that produced tetrahydroalstonine, although this protein was purified only 35-fold from *C. roseus* cell cultures. Consistent with [@bib18] nomenclature, we named this enzyme tetrahydroalstonine synthase (THAS). A minor enzymatic product was produced in yields too low for NMR characterization, but had a mass and *R*~f~ value consistent with ajmalicine, a stereoisomer of tetrahydroalstonine ([Figure S2](#app2){ref-type="sec"}). When applied to normal phase liquid chromatography conditions, ajmalicine and tetrahydroalstonine could be resolved, indicating that the enzyme produces approximately 95% tetrahydroalstonine ([Figure 3](#fig3){ref-type="fig"}; [Supplemental Information](#app2){ref-type="sec"}). We also silenced this gene in *C. roseus* seedlings using virus-induced gene silencing (VIGS) ([@bib25]). LC-mass spectrometry (MS) analysis of the silenced leaf tissue showed a statistically significant decrease (approximately 50%) of a peak with a mass and retention time consistent with a heteroyohimbine, suggesting that this enzyme is involved in this biosynthetic pathway branch in vivo ([Figure S2](#app2){ref-type="sec"}). A 50% reduction in product levels upon silencing has been observed for other physiologically relevant biosynthetic genes using the VIGS approach in both *C. roseus* ([@bib1; @bib14]) and another well-studied medicinal plant, opium poppy ([@bib10; @bib6]). Therefore, THAS is likely a major producer of tetrahydroalstonine in vivo, although additional, undiscovered *C. roseus* enzymes could also contribute to production of this compound. While we could not resolve tetrahydroalstonine and its stereoisomer ajmalicine in the silenced crude extracts, the levels of the ajmalicine-derived alkaloid serpentine remain the same, suggesting that silencing of THAS does not substantially affect ajmalicine levels and consequently that THAS does not play a major role in the biosynthesis of ajmalicine in planta.

Small-scale assays using LC-MS to monitor product formation indicated that NADPH was required for the reaction, although NADH could also be utilized ([Figure S1](#app2){ref-type="sec"}). Efforts to accurately measure the steady state kinetic constants of this enzyme were complicated because strictosidine aglycone reacts with nucleophiles, opening the possibility that the substrate reacts with components in the reaction or the enzyme. This reactivity has already been associated with a plant defense mechanism involving strictosidine aglycone-mediated aggregation of proteins in *C. roseus* ([@bib17]). Nevertheless, we obtained estimated *K*~m~ and *k*~cat~ values ([Figure S1](#app2){ref-type="sec"}). To support these kinetic data, we also performed isothermal titration calorimetry (ITC) with THAS in the presence of NADPH and strictosidine aglycone. Titration of THAS with NADPH indicated that the cosubstrate binds first with a *K*~d~ of 1.5 ± 0.1 μM (Δ*H* (cal/mol) 2310 ± 123.2; Δ*S* (cal/mol/deg) 34.2 ± 0.3) ([Figure S1](#app2){ref-type="sec"}). The aglycone substrate does not appear to bind in the absence of NADPH, suggesting that the enzyme utilizes an ordered binding mechanism in which NADPH binds first. However, titration of the THAS-NADPH complex with strictosidine aglycone led to formation of a precipitate when concentrations of strictosidine aglycone exceeded 60 μM, preventing calculation of an accurate *K*~d~. Collectively, the ITC data for THAS are consistent with an ordered Bi-Bi mechanism, a kinetic mechanism that has been reported for similar ADHs such as cinnamyl alcohol dehydrogenase ([@bib5; @bib24]).

The amino acid sequence of THAS was subjected to a BLAST alignment against the *C. roseus* transcriptome ([@bib15]), as well as the NCBI ([Figure S3](#app2){ref-type="sec"}). The closest characterized homologs of THAS are sinapyl alcohol dehydrogenase (*Populus tremuloides*, 64% amino acid identity), cinnamyl alcohol dehydrogenase (*Populus tomentosa*, 64%) and 8-hydroxygeraniol dehydrogenase (*C. roseus*, 63%), which are zinc-containing medium chain ADHs ([@bib2; @bib24]).

Strictosidine aglycone can rearrange into several isomers ([Figure 1](#fig1){ref-type="fig"}B), and while it has been reported that the dominant isomer is cathenamine ([@bib13; @bib31]), equilibration in solution with other isomers occurs ([@bib3; @bib32]). Reduction of cathenamine or epi-cathenamine ([Figure 1](#fig1){ref-type="fig"}B) by a reductase would require reduction of the carbon-carbon double bond of an enamine; alternatively, [@bib32] and [@bib35] suggested that the iminium isomer is reduced ([Figure 1](#fig1){ref-type="fig"}B). THAS may catalyze the stereoselective formation of tetrahydroalstonine by selectively binding the correct isomer of the substrate for reduction, thereby relying on the inherent propensity for the enamine and imine to tautomerize under physiological conditions. Given that three diastereomers, ajmalicine, tetrahydroalstonine, and 19-epi-ajmalicine, can be obtained from chemical reduction of strictosidine aglycone, this is a chemically reasonable proposal. An alternative hypothesis is that THAS catalyzes enamine-imine tautomerization in addition to reduction. The difficulties associated with obtaining accurate kinetic data in this system, as well as the inherent reactivity of the strictosidine aglycone, make answering these questions using enzymology approaches challenging. However, identification and comparison with enzymes that generate other heteroyohimbine diastereomers will likely provide the basis for a more definitive mechanism of product specificity.

Recent research has highlighted that plant secondary metabolite biosynthetic pathways often are compartmentalized in different subcellular locations. While microscopy experiments have demonstrated that most of the early steps of monoterpene indole alkaloid biosynthesis in *C. roseus* take place in the cytosol ([@bib8]), the enzyme that synthesizes strictosidine is located in the vacuole, and the enzyme SGD, which deglycosylates strictosidine, contains a nuclear localization signal and is in the nucleus, a highly unusual site for secondary metabolite biosynthesis ([@bib17]). Notably, a motif resembling a class V nuclear localization sequence ([@bib23]) was observed in THAS (K~214~K~215~K~216~R~217~). Microscopy of *C. roseus* cells transformed with YFP-tagged THAS confirmed the nuclear location of this enzyme, while deletion of the KKKR sequence disrupted the localization ([Figure 4](#fig4){ref-type="fig"}A; [Figure S4](#app2){ref-type="sec"}). This is one of the very few examples of secondary metabolism that is localized to the nucleus ([@bib29]).

Given the reactivity of strictosidine aglycone ([@bib17]), metabolic channeling via a protein-protein interaction between SGD and the enzyme immediately downstream may be necessary to protect the substrate. Pull down experiments between SGD and THAS gave partially positive but inconclusive results ([Figure S4](#app2){ref-type="sec"}). However, when we used bimolecular fluorescence complementation (BiFC) in *C. roseus* cells, we observed an interaction between SGD and THAS ([Figure 4](#fig4){ref-type="fig"}B). While this interaction generated a diffuse nuclear fluorescent signal when the C-terminal end of SGD was fused to the split-YFP fragment, a sickle-shaped signal was observed when both SGD and THAS were expressed with free C-terminal ends (YFP^N^-SGD and YFP^C^-THAS). Such a signal was also observed for SGD self-interactions ([@bib17]) and likely results from the formation of SGD complexes over 1.5 MDa ([@bib26]). Similar experiments with SGD and an upstream MIA biosynthetic enzyme, loganic acid methyl transferase, failed to show an interaction, highlighting the specificity of this interaction ([Figure S4](#app2){ref-type="sec"}). The fact that THAS interacts with SGD provides further support for the physiological relevance of THAS in planta. As strictosidine aglycone is reactive and most likely toxic in vivo, it has been proposed that this molecule is produced by the plant in response to attack ([@bib17]). The nuclear localization of THAS might be an evolutionary mechanism designed to channel this molecule into a more stable product when no such defense is required. Identification of additional nuclear-localized biosynthetic enzymes in *C. roseus* and other heteroyohimbine producing plants may provide more insight into the reasons for this unusual localization pattern.

Significance {#sec3}
============

**Many of the monoterpene indole alkaloid structural classes are generated at the SGD junction. Here we report the first identification of a biosynthetic gene that acts directly downstream of SGD. The enzyme, an ADH homolog, generates a heteroyohimbine alkaloid by reducing one of the isomers of strictosidine aglycone. Unusually, this enzyme is located in the nucleus and may interact with its upstream partner, SGD. The discovery of the THAS gene represents the completion of a major branch of monoterpene indole alkaloid biosynthesis, which will now allow reconstruction of heteroyohimbines and heteroyohimbine analogs in heterologous hosts. This discovery is a crucial first step in understanding how the structural diversity of MIAs is controlled.**

Experimental Procedures {#sec4}
=======================

The THAS gene (accession number [KM524258](ncbi-n:KM524258){#intref0010}) was cloned into pOPINF and expressed in Rosetta 2 pLysS *E. coli* cells (Novagen) with induction of expression with 0.1 mM isopropyl β-D-1-thiogalactopyranoside. Cultures were grown at 18°C for 16 hr, with shaking at 200 rpm. His-tagged THAS was purified using a HisTrap FF 5-ml column (GE Healthcare). SGD expression and purification was done as described for THAS using the expression system described previously by [@bib34]. Purified THAS and SGD were used in all assays. Strictosidine was enzymatically synthesized from tryptamine and a crude methanol extract of snowberries (*Symphoricarpos albus*) enriched in secologanin prepared as previously described ([@bib12]). Strictosidine aglycone was generated in situ prior to addition of THAS by incubation of strictosidine and SGD in the appropriate solution for 10 min, at which time strictosidine was completely converted to the aglycone.

Steady state kinetic analyses were performed with 50 nM THAS and 6 nM SGD, 50 mM phosphate buffer (pH 7.5), 200 μM NADPH, and an internal caffeine standard (50 μM). All LC-MS measurements were performed on AQUITY ultraperformance liquid chromatography with a Xevo TQ-S mass spectrometer.

For VIGS, a 330-bp fragment of THAS was cloned into the pTRV2u vector as described ([@bib14]). The resulting pTRV2u-THAS construct was used to silence THAS in *C. roseus* seedlings essentially as described ([@bib25]).

The subcellular localization of THAS was studied by creating fluorescent fusion proteins using the pSCA-cassette YFPi plasmid ([@bib16; @bib17]). The capacity of interaction of THAS and SGD was characterized by BiFC assays using THAS PCR product cloned via *Spe*I into the pSPYCE(MR) plasmid ([@bib33]), which allows expression of THAS fused to the carboxy-terminal extremity of the split YFP^C^ fragment (YFP^C^-THAS). The pSCA-SPYNE173-SGD and pSPYNE(R)173-SGD plasmids ([@bib17]) were used to express SGD fused to the amino-terminal or carboxy-terminal extremity of the split YFP^N^ fragment (SGD-YFP^N^ and YFP^N^-SGD, respectively). THAS self-interactions were analyzed via additional cloning of the THAS PCR product into the pSCA-SPYNE173 and pSCA-SPYCE(M) plasmids ([@bib17]) to express THAS-YFP^N^ and THAS-YFP^C^, respectively. Transient transformation of *C. roseus* cells by particle bombardment and fluorescence imaging were performed following the procedures previously described ([@bib16; @bib17]).

Complete experimental details are included in the [Supplemental Information](#app2){ref-type="sec"}.

Author Contributions {#sec5}
====================

A.S. made the initial discovery of THAS activity and conducted all enzyme assays, kinetics, pulldown, and ITC; E.C.T. performed VIGS and assisted in the structural characterization of the enzyme product; E.F. performed the microscopy experiments; L.C. assisted in the purification of THAS and pulldown; F.K. provided initial genomic data that assisted in identification of the THAS candidate; V.C. conceived, initiated, and supervised all localization and BiFC experiments; S.E.O. supervised all enzymology experiments; A.S., V.C., S.E.O. wrote the manuscript.

Supplemental Information {#app2}
========================

Document S1. Figures S1--S4 and Supplemental Experimental ProceduresDocument S2. Article plus Supplemental Information

We gratefully acknowledge support from the ERC (311363) and from the Région Centre (France, ABISAL grant). A.S. is supported by a BBSRC DTP studentship.

This is an open access article under the CC BY license (<http://creativecommons.org/licenses/by/4.0/>).

![The Monoterpene Indole Alkaloids\
(A) Representative monoterpene indole alkaloids derived from strictosidine and strictosidine aglycone found in *Catharanthus roseus*.\
(B) Heteroyohimbine biosynthesis.](gr1){#fig1}

![Activity Assays of THAS\
Enzyme reactions were performed at 25°C for 30 min and assayed using a mass spectrometer in tandem with ultraperformance liquid chromatography.\
(A) The total ion chromatogram for *m*/*z* 353 (red trace) and *m*/*z* 351 (purple trace) from 1 to 4 min is shown. Top trace: THAS (50 nM), SGD (6 nM), strictosidine (200 μM), NADPH (200 μM); bottom trace: same reaction in the absence of THAS. The *y* axis represents normalized ion abundance as a percentage relative to 1.00e^8^ detected by selected ion monitoring at *m*/*z* 353 and 351.\
(B) Portion of the ^1^H-NMR spectrum of the isolated enzymatic product compared with an authentic standard of tetrahydroalstonine.](gr2){#fig2}

![LC-MS Performed under Normal Phase Conditions (Hydrophilic Interaction Liquid Chromatography) Showing Separation of Ajamlicine (Retention Time of 0.49 min) and Tetrahydroalstonine (THA, Retention Time 0.67 min)\
THAS produces approximately 95% of the tetrahydroalstonine (THA) diastereomer. The *y* axis represents normalized ion abundance as a percentage detected by selected ion monitoring at *m*/*z* 353.](gr3){#fig3}

![THAS Is Targeted to the Nucleus via a Monopartite Nuclear Localization Signal (NLS) and Interacts with SGD\
(A) *C. roseus* cells were transiently cotransformed with plasmids expressing either THAS-YFP (upper row), YFP-THAS (middle row), or the NLS deleted version of THAS (lower row) and plasmids encoding the nuclear CFP marker or the nucleocytosolic CFP marker (second column). Colocalization of the fluorescence signals appears in yellow when merging the two individual (green/red) false color images (third column). Cell morphology is observed with differential interference contrast (DIC) (fourth column).\
(B) THAS and SGD interactions were analyzed by BiFC in *C. roseus* cells transiently transformed by plasmids encoding fusions indicated on the top (fusion with the split YFP^N^ fragment) and on the left (fusion with split YFP^C^ fragment). bZIP63 was used as a positive BiFC control and to evaluate the specificity of THAS and SGD interactions. The images are merges of the YFP BiFC channel (magenta false color) with the DIC channel to show the nuclear localization of the interactions. Bars, 10 μm.](gr4){#fig4}
